The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD’s Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, N.Y., Oct. 3, 2023 /PRNewswire/ — EQUASHIELD®, a leading provider of Closed System…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.